Lipocine Inc New (LPCN) Hedge Fund Ownership (Q2 2026)

Lipocine Inc New (LPCN)

35 + Investors. Track Smart Money conviction in LPCN. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — LPCN

Based on 35 hedge funds · latest filing: 2026 Q2 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q

For 1 consecutive quarter, more hedge funds reduced or closed their LPCN positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

📊

High ownership — 80% of 3.0Y peak

80% of all-time peak

35 funds currently hold this stock — 80% of the 3.0-year high of 44 funds (reached 2026 Q1). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.

🚀

Fast accumulation — +94% more funds vs a year ago

fund count last 6Q

+17 new funds entered over the past year (+94% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.

🟡

Slight buying edge — 53% buying

18 buying16 selling

Last quarter: 18 funds bought or added vs 16 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

⚠️

Fewer new buyers each quarter (-18 vs last Q)

new funds entering per quarter

Funds opening this position for the first time: 3 → 9 → 22 → 4. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.

📌

Mixed — 37% long-term, 51% new

■ 37% conviction (2yr+) ■ 11% medium ■ 51% new

Of the 35 current holders: 13 (37%) held >2 years, 4 held 1–2 years, and 18 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

💎

Buying through price weakness — shares -4%, value -71%

Value

-71%

-4%

Last quarter: funds added -4% more shares while total portfolio value only changed -71%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.

➡️

Steady discovery — ~4 new funds/quarter

1 → 3 → 9 → 22 → 4 new funds/Q

New funds entering each quarter: 3 → 9 → 22 → 4. Consistent flow of new institutional buyers without clear acceleration or slowdown.

📊

Mixed cohorts — 37% veterans, 51% new entrants

■ 37% veterans ■ 11% 1-2yr ■ 51% new

Of 35 current holders: 13 (37%) held 2+ years, 4 held 1–2 years, 18 (51%) entered in the past year. Balanced distribution — some institutional memory, some recent momentum buyers.

📋

Smaller funds dominant — 15% AUM from top-100

15% from top-100 AUM funds

11 of 35 holders rank in the top 100 by AUM, but together hold only 15% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

4.9

out of 10

Moderate Exit Risk

Exit risk score 4.9/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q2)	Prior (2026 Q1)	Change
Funds Holding	35	44	-20.45%
13F Shares	3M	3M	-4.41%
Total Value	$7M	$25M	-71.45%
New Positions	4	22	-18
Increased Positions	14	9	+5
Closed Positions	13	4	+9
Reduced Positions	3	9	-6
Total Calls	0	0	-
Total Puts	0	0	-
PUT/CALL Ratio	0.0	0.0	Bullish

Metric

All 13F Filers (2026 Q2)

Prior (2026 Q1)

Change

Funds Holding

-20.45%

13F Shares

-4.41%

Total Value

$7M

$25M

-71.45%

New Positions

-18

Increased Positions

Closed Positions

Reduced Positions

-6

Total Calls

Total Puts

PUT/CALL Ratio

0.0

Bullish

Institutional Holders (2026 Q2)

35 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in LPCN. Verified SEC 13F-HR filings.

QUARTER:

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 LPCN holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Squadron Capital Management LLC	0.64%	810,000	$2.1M
2	Ikarian Capital, LLC	0.14%	508,556	$1.3M
3	Eversept Partners, LP	0.04%	294,989	$755K
4	Seven Fleet Capital Management LP	0.03%	78,842	$202K
5	Birchview Capital, LP	0.02%	16,712	$43K
6	Boothbay Fund Management, LLC	0.00%	140,487	$360K
7	Caldwell Sutter Capital, INC.	0.00%	471	$1K
8	Renaissance Technologies LLC	0.00%	69,209	$177K
9	PlanVest Financial, Inc	0.00%	111	—
10	Two Sigma Investments, LP	0.00%	84,887	$217K
11	Hrt Financial LP	0.00%	29,238	$74K
12	Tower Research Capital LLC (TRC)	0.00%	678	$2K
13	Tidemark, LLC	0.00%	59	—
14	Vanguard Fiduciary Trust Co	0.00%	54,539	$140K
15	Citadel Advisors LLC	0.00%	81,221	$208K
16	Jane Street Group, LLC	0.00%	95,227	$244K
17	Vanguard Capital Management LLC	0.00%	230,823	$591K
18	Susquehanna International Group, LLP	0.00%	25,376	$65K
19	Barclays plc	0.00%	9,827	$25K
20	SBI Securities Co., Ltd.	0.00%	67	—
21	BlackRock, Inc.	0.00%	89,272	$229K
22	UBS Group AG	0.00%	3,596	$9K
23	Wells Fargo & Company/Mn	0.00%	2,706	$7K
24	Osaic Holdings, INC.	0.00%	238	—
25	Group One Trading LLC	0.00%	132	—

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Lipocine Inc New (LPCN)

What does the Smart Money Trend signal show for LPCN?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their LPCN positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for LPCN?

Slight buying edge — 53% buying: Last quarter: 18 funds bought or added vs 16 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for LPCN holders?

Smaller funds dominant — 15% AUM from top-100: 11 of 35 holders rank in the top 100 by AUM, but together hold only 15% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held LPCN?

Mixed — 37% long-term, 51% new: Of the 35 current holders: 13 (37%) held >2 years, 4 held 1–2 years, and 18 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Lipocine Inc New (LPCN)

Smart Money Signals — LPCN

Selling streak — 1 quarter in a row

High ownership — 80% of 3.0Y peak

Fast accumulation — +94% more funds vs a year ago

Slight buying edge — 53% buying

Fewer new buyers each quarter (-18 vs last Q)

Mixed — 37% long-term, 51% new

Buying through price weakness — shares -4%, value -71%

Steady discovery — ~4 new funds/quarter

Mixed cohorts — 37% veterans, 51% new entrants

Smaller funds dominant — 15% AUM from top-100

Institutional Sentiment Summary — LPCN

Hedge Fund Ownership: LPCN

Market Analysis: LPCN

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: LPCN

Hedge Fund Positioning: LPCN

Statistics: LPCN

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Lipocine Inc New (LPCN)

Welcome to 13Foresight!